Search

L. Ardighieri

FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment

Published with Wowchemy — the free, open source website builder that empowers creators.